Gene/signaling pathway | Oestrogen receptor type participating in action | Author (year) | |
---|---|---|---|
Cell proliferation | |||
Oncogenes | BMI-1 | ERβ | Mak et al. (2006) |
Twist | ERβ2 | Dey et al. (2012) | |
Suppressors | PTEN | ERα | Takizawa et al. (2015) |
MAPK | ERα | Takizawa et al. (2015) | |
Cell cycle control | p21 | ERβ | Colciago et al. (2014) |
CCND1 | ERβ | Nakamura et al. (2013) | |
c-Myc | ERβ2 | Dey et al. (2012) | |
Signaling pathways | PI3 K | ERα | Takizawa et al. (2015) |
mTOR | ERα and ERβ | Wang et al. (2014) | |
Apoptosis | |||
Proapoptotic | Bax | ERβ | Cheng et al. (2004) |
Cleaved caspase-3 | ERβ | Cheng et al. (2004) | |
p-53 | ERs | Kanagaraj et al. (2007) | |
FOXO3 and PUMA | ERβ | Dey et al. (2014) | |
Pro/antiapoptotic | TGF-β1 | ERs | Chipuk et al. (2001) |
Epithelial-mesenchymal transition (EMT) | |||
↓EMT | PHD2/EGLN1 | ERβ1 | |
HIF1-α | ERβ1 | ||
Snail1 | ERβ1 | ||
Runx 2 | ERβ2 | Dey et al. (2012) | |
TGF-β1 | ERβ | Hu et al. (2015) | |
E-cadherin | ERβ | Hu et al. 2015 | |
Thbs2 | ERα | Slavin et al. (2014) | |
MMP3 | Slavin et al. (2014) | ||
↑EMT | SOX4 | ERβ | Mak et al. (2010) |
Twist1 | ERβ2 | Dey et al. (2012) | |
c-Myc | ERβ2 | Dey et al. (2012) | |
HIF-1α | ERβ2 and ERβ5 | Dey et al. (2015) | |
Runx 2 | ERβ1 | Dey et al. (2012) | |
NEAT-1 | ERβ | Chakravarty et al. (2014) | |
Chronic inflammation | |||
↑ | HIF-1α | ERα | |
NF-κB | ERα |